Navigation Links
Unlikely Drugs Emerge as 'Cognition Enhancers'

Medications to treat ADHD, heart problems becoming popular, survey finds

WEDNESDAY, April 9 (HealthDay News) -- One in five respondents to a new survey acknowledges using so-called "cognition-enhancing drugs" -- such as ADHD and heart medications -- to stimulate their focus, concentration or memory.

The most popular drug was Ritalin (methylphenidate), which is prescribed to treat attention deficit hyperactivity disorder, but has emerged in recent years as a campus "study aid." Coming in second was the stimulant Provigil (modafinil), followed by blood-pressure drugs called beta blockers, which can also help to reduce anxiety.

The online survey was open to subscribers of Nature -- who tend to be researchers and scientists -- and the results are published in the April 10 issue of the scientific journal. The survey found that people of all ages are using these drugs for cognitive enhancement.

That flies in the face of conventional wisdom that suggests stimulant use is highest among people 18 to 25 years old and students, Dr. Nora Volkow, director of the U.S. National Institute on Drug Abuse, noted in the report.

Ritalin was the most popular drug, with 62 percent of users reporting having taken it. Forty-four percent of the respondents -- more than 1,400 people from 60 countries -- said they'd taken Provigil, while 15 percent said they'd taken beta blockers such as propanolol.

Other popular drugs of choice included adderall, an amphetamine similar to Ritalin; centrophenoxine, which is used to treat dementia; and dexedrine, an amphetamine. Supplements such as ginkgo and omega-3 fatty acids were also commonly used, according to the poll.

One third of those using drugs for non-medical purposes said they'd bought them over the Internet. Others got them from pharmacies or with a prescription, according to the survey

The most common reason given for taking any of these drugs was to boost concentration. Combating jet lag was another frequent reason cited by the respondents.

Eighty-six percent of the respondents said they thought children under 16 years of age should be prevented from using these drugs. But one third said they'd feel pressured to give the drugs to their children if other kids at school were using them.

Dr. Anjan Chatterjee, a neuroscientist at the University of Pennsylvania, predicted that the use of these drugs and other "neuro-enhancing" products and procedures will continue to grow in popularity as they become available, he said in the Nature report. One reason that use of these drugs is on the rise is that they don't rely on training of medical specialists, he noted.

About 50 percent of those taking these drugs reported unpleasant side effects, including headaches, jitteriness, anxiety and sleeplessness. These side effects made some people stop using the drugs.

More information

To learn more about so-called "smart drugs," visit the University of Washington.

SOURCE: Nature, April 10, 2008

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. U.S. Unlikely to Meet Target for TB Elimination
2. Switching to MA Coverage Unlikely for Current Beneficiaries With MediGap or Medicare Only
3. R rating might be unlikely to affect teens exposure to smoking in movies
4. Finasteride unlikely to induce high grade prostate cancers
5. National Healthcare Decisions Survey: Its Easier to Talk About Drugs and Sex Than End-of-Life Planning
6. Pennsylvania Health Plans Employ Various Strategies to Combat Cost of Specialty Drugs
7. Faster Test Detects Fake Tamiflu Drugs
8. Nanomachine Releases Anticancer Drugs Inside Cells
9. Fred Meyer, QFC Introduce $4 Generic Drugs
10. Ralphs Introduces $4 Generic Drugs
11. Indiana Adopts Legislation to Combat Illegitimate Online Pharmacies, Protect Residents From Counterfeit Drugs
Post Your Comments:
Related Image:
Unlikely Drugs Emerge as 'Cognition Enhancers'
(Date:11/27/2015)... ... November 27, 2015 , ... The men and ... nonprofit healthcare organizations in the country. They have overseen financial turnarounds, shown commitment ... advance the healthcare industry as a whole through their advocacy and professional efforts. ...
(Date:11/27/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk ... Term Support) into its Q-Suite 5.10 product line. , Making the change to ... of Asterisk that will receive not only security fixes, but feature and bug ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, family ... tests directly from their electronic medical record (EMR) without the need for redundant ...
(Date:11/26/2015)... ... 2015 , ... Jobs in hospital medical laboratories and in the imaging field ... agency Aureus Medical Group . These fields, as well as travel ... for healthcare jobs through the company’s website, , The leading healthcare ...
(Date:11/26/2015)... , ... November 26, 2015 , ... ... set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly styled ProTrailer ... classically-influenced trailer titles work with any font, giving users limitless opportunities to stylize ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... 26, 2015 ... the "2016 Global Tumor Marker Testing ... and Sales Segment Forecasts, Innovative Technologies, Instrumentation ... to their offering. --> ... "2016 Global Tumor Marker Testing Market: ...
(Date:11/26/2015)... , November 26, 2015 ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... has found that immunotherapy can be efficiently combined ...
(Date:11/26/2015)... 2015 3D bioprinting market is ... a new report by Grand View Research Inc. Rising prevalence ... demands kidney transplantation is expected to boost the market growth, ... organ transplantation. --> 3D bioprinting market is ... a new report by Grand View Research Inc. Rising prevalence ...
Breaking Medicine Technology: